Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cottrell

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Scientific Reports|April 27, 2026
Site-specific variation and non-indigenous species detection in Arabian Gulf biofouling communities using DNA metabarcoding and photographic surveysSahar Chebaane, Eva Aylagas, Juan Sempere-Valverde, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Scientific Reports|April 27, 2026
Site-specific variation and non-indigenous species detection in Arabian Gulf biofouling communities using DNA metabarcoding and photographic surveysSahar Chebaane, Eva Aylagas, Juan Sempere-Valverde, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of Thienoimidazole-Based HCV NS5A Genotype 1a and 1b InhibitorsSimon Giroux, Jinwang Xu, T Jagadeeswar Reddy, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 1: C2-symmetric inhibitors with diyne and biphenyl linkersSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
Discovery of thienoimidazole-based HCV NS5A inhibitors. Part 2: non-symmetric inhibitors with potent activity against genotype 1a and 1bSimon Giroux, Darius Bilimoria, Caroline Cadilhac, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Inhibitors of hepatitis C virus NS3.4A protease. Part 3: P2 proline variantsRobert B Perni, Luc J Farmer, Kevin M Cottrell, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Synthesis and evaluation of NS5A inhibitors containing diverse heteroaromatic coresJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Bioorganic & Medicinal Chemistry Letters|January 12, 2015
Benzimidazole-containing HCV NS5A inhibitors: effect of 4-substituted pyrrolidines in balancing genotype 1a and 1b potencyJames A Henderson, Darius Bilimoria, Monica Bubenik, et al.
Pageof 17